Sitafloxacin Fumarate

Main research purpose: According to the relevant provisions of bioequivalence test, the sitafloxacin granules (specification: 10% (30g)) of Daiichi Sankyo Co., Ltd. as the licensee was selected as the reference preparation, and the test preparation sitafloxacin granules (specification: 50mg) produced by Jichuan Pharmaceutical Group Co., Ltd. were subjected to fasting and postprandial bioequivalence test to compare whether the absorption rate and degree of the drug in the test preparation were within the acceptable range with the reference preparation, and to compare the bioequivalence of the two preparations under fasting and postprandial administration conditions. Secondary research purpose: To observe the safety of oral administration of the test preparation sitafloxacin granules (specification: 50mg) and the reference preparation sitafloxacin granules (specification: 10% (30g)) by healthy volunteers.